MWA
TEVA icon

Medallion Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Medallion Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.01K Hold
100
– – ﹤0.01% 951
2025
Q4 		$3.12K Hold
100
– – ﹤0.01% 926
2025
Q3 		$2.02K Hold
100
– – ﹤0.01% 975
2025
Q2 		$1.66K Hold
100
– – ﹤0.01% 976
2025
Q1 		$1.53K Hold
100
– – ﹤0.01% 950
2024
Q4 		$2.2K Buy
+100
New +$1.82K ﹤0.01% 848

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Medallion Wealth Advisors's TEVA Position: Q1 2026 in Review

Medallion Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 100 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Medallion Wealth Advisors first reported a position in TEVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.12K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Medallion Wealth Advisors held 100 shares of Teva Pharmaceuticals worth $3.01K as of Q1 2026.
  • Medallion Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q1 2026, its #951 holding.
  • Medallion Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's Teva Pharmaceuticals position peaked at $3.12K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.